CIK 0001422143
- Non-accelerated filer
- Smaller reporting company
Kura Oncology, Inc.
Sign in to watch- Ticker
- KURA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 611547851
- Phone
- +1 858-500-8800
- Business address
- 4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
- Former names
- ZETA ACQUISITION CORP III
- Open-market buys, last 90 days
- $4,248,530
- in 3 filings
- Open-market sales, last 90 days
- $1,929,830
- in 12 filings, $348K under 10b5-1 plans
Net +$2,318,700. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- WILSON TROY EDWARD +$4.2M President and CEO 3 filings
- Leoni Mollie −$747K Chief Medical Officer sold 45% of stake
- Powl Brian T. −$530K Chief Commercial Officer sold 34% of stake
- Burrows Francis −$225K Chief Scientific Officer sold 33% of stake
- FORD KATHLEEN −$192K Chief Operating Officer sold 14% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-12 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +10,000 | 10,000 | ||
| 2016-01-29 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +125,000 | 125,000 | ||
| 2016-01-29 | REN PINGDA SVP-Chemistry&Pharma Sciences | Grant or award · Option to purchase common stock | +50,000 | 50,000 | ||
| 2016-01-29 | LIU YI Chief Scientific Officer | Grant or award · Option to purchase common stock | +50,000 | 50,000 | ||
| 2016-01-29 | North Annette SVP, General Counsel | Grant or award · Option to purchase common stock | +80,000 | 80,000 | ||
| 2016-01-29 | GUALBERTO ANTONIO Chief Medical Officer | Grant or award · Option to purchase common stock | +75,000 | 75,000 | ||
| 2016-01-29 | HENSON HEIDI Chief Financial Officer | Grant or award · Option to purchase common stock | +80,000 | 80,000 | ||
| 2016-01-29 | WILSON TROY EDWARD President and CEO | Grant or award · Option to purchase common stock | +120,000 | 120,000 | ||
| 2015-11-10 | Malley Thomas Director | Purchase | +50,000 | $8.00 | $400K | 89,557 |
| 2015-10-13 | Malley Thomas Director | Grant or award · Option to purchase common stock | +30,000 | 30,000 | ||
| 2015-04-23 | HOFFMAN ROBERT Director | Grant or award · Option to purchase common stock | +30,000 | 30,000 | ||
| 2015-04-23 | North Annette SVP, General Counsel | Grant or award · Option to purchase common stock | +81,250 | 81,250 | ||
| 2015-04-23 | Hasnain Faheem Director | Grant or award · Option to purchase common stock | +30,000 | 30,000 | ||
| 2015-03-06 | PAPPAJOHN JOHN President | Returned to the company | −2,000,000 | 0 | ||
| 2015-03-06 | VASSILIOU ARGYRIS 10% owner | Returned to the company | −625,000 | 0 | ||
| 2015-03-06 | VASSILIOU ARGYRIS 10% owner | Returned to the company | −375,000 | 0 | ||
| 2015-03-06 | KINLEY MATTHEW P Secretary, CFO | Returned to the company | −2,000,000 | 0 |
Page 21 of 21 · 417 trades